ORTEXORTEX News
Tracking ADP? Get live short interest, options flow, and signals on ORTEX.Sign up free →
AD
Trader NoteADP

ADP Holds Its Ground as Peers Slide

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 28 Oct 2026, 17:54

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Automatic Data Processing is the quietest stock in a noisy peer group this week, flat on the week while the closest comparables sold off sharply, and that relative calm is backed by some of the loosest short positioning in the sector.

Most payroll and workforce-data names had a rough week. PAYX fell nearly 3% over the five sessions. TRU dropped 3.6%. VRSK shed 1.6%. ADP closed up 0.1% against a median decline of around 1% across its eight closest peers, a spread that reflects the defensive character of its recurring-revenue model rather than any stock-specific catalyst. The one-day picture is less flattering: ADP dropped 2.7% on October 27, broadly in line with the sector, but the weekly comparison holds.

Where ADP parts company most clearly with peers is in the lending market. Availability is exceptionally loose at roughly 6,100%, meaning there are around 60 shares available to borrow for every one currently lent out. That is well above the 52-week floor of 1,234%, itself a level that would be considered ample for most names. Short interest at 2.5% of the free float is low by any measure, and it fell another 7.7% across the past week. Borrow costs at 0.52% are negligible. There is simply no short-side pressure here: the lending market is as relaxed as it has been all year.

The analyst picture is more divided than the positioning suggests. The consensus sits at hold, with 11 hold ratings and 2 underperform, and the mean price target of $290.40 is fractionally below the current price of $293.11. Guggenheim is the outlier: the firm raised its target to $340 on October 23, the most recent analyst action and the most bullish on the Street. The bull case rests on the durability of ADP's payroll infrastructure across 1.1 million clients and 42 million workers, with FY27 Employer Services growth expected around 5% to 6% and AI-driven margin efficiencies providing a further leg. Bears focus on PEO, where healthcare inflation running at 9% threatens retention and SMB benefit spend as the F4Q renewal season approaches. The dividend score ranks in the 98th percentile, one of the strongest readings in the universe, which matters to the income-oriented holders who dominate the register.

Institutional ownership is concentrated and largely passive. BlackRock holds 9.1% and State Street 5.1%, both recently reported. The Vanguard Group filed a 13G/A in March showing a stake that had declined to zero from 10.1%, while Vanguard Capital Management separately filed a 13G in April at 7.5%. No 13D activist is on the register. All recent insider sales, including CEO Maria Black's September disposals totalling around $3 million, were executed under pre-arranged 10b5-1 plans, so they carry little informational weight.

Retail attention is notably elevated. An ORTEX Wikipedia-views signal scores a z-score of 4.1 against ADP's own 90-day history, a reading that reflects how much attention the stock is drawing rather than any revenue indicator. The next earnings date is November 11. The question at that print is whether PEO margins hold up against the healthcare cost headwind, and whether Employer Services bookings show any pull-forward from the new benefits enrollment initiative.

Stocks in this article

See the live data behind this article on ORTEX.

Open ADP on ORTEX →

How this article was generated

Generated
28 Oct 2026, 18:04
Data as of
28 Oct 2026, 17:54
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.